BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//REMEDi4ALL - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:REMEDi4ALL
X-ORIGINAL-URL:https://remedi4all.org
X-WR-CALDESC:Events for REMEDi4ALL
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Amsterdam
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20220916T000000
DTEND;TZID=Europe/London:20220916T180000
DTSTAMP:20260423T003205
CREATED:20220819T094616Z
LAST-MODIFIED:20220819T094616Z
UID:230-1663286400-1663351200@remedi4all.org
SUMMARY:CeBIL Annual Symposium 2022 - Intellectual Property and Drug Repurposing: New Frontiers
DESCRIPTION:Repurposing\, the idea of finding new treatments for already authorised drugs\, presents significant advantages for drug development. Modern drug development is hindered by high costs and research that takes over a decade. \nRepurposing is a potential solution to these problems because it is cheaper\, faster and safer than developing new compounds. However\, academics\, policymakers and industry experts argue that repurposing is underutilised\, pointing at gaps in patent and pharmaceutical law that make it financially unviable. \nThe symposium will focus on important policy issues for pharmaceutical repurposing. In particular\, it will examine new empirical data on patent protection\, regulatory exclusivities and market authorisation pathways. It will also discuss two new public sector repurposing initiatives launched in the UK and EU\, and investigate other policy frontiers. It will have a hybrid format\, with both in-person and online only tickets available. \nThe 2022 CeBIL Symposium is organised by the Cambridge Centre for Law\, Medicine and Life Sciences (LML) in combination with the Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) at the University of Copenhagen. The Symposium is generously supported by the Novo Nordisk Foundation. \nHosted by the University of Cambridge\, an international hub for legal and scientific expertise\, we hope the event will stimulate discussion between legal\, economic\,business\, medical\, and scientific experts at a range of career stages. \nConfirmed participants include: \n\nProf. Timo Minssen (CeBIL\, University of Copenhagen)\nProf. Kathleen Liddell (LML\, University of Cambridge)\nProf. Mateo Aboy (LML\, University of Cambridge)\nDr Jakob Wested (CeBIL\, University of Copenhagen & Danish Medicines Agency)\nMs Eugenia Wachters (Healx)\nDr Anita Marguerie de Rotrou (Office for Translational Research\, University of Cambridge)\nMr Adrian Freeman (AstraZeneca)\nProfessor Ken Shadlen (London School of Economics)\nDr John Liddicoat (LML\, University of Cambridge)\nDr Rosemary Lovett (Medicines Repurposing Programme\, NHS England)\nDr Charlotte Asker-Hagelberg (Swedish Medical Products Agency)\nDr Julian Huppert (Intellectual Forum\, Jesus College\, University of Cambridge)\nDr Marco Schito (Critical Path Institute)\nMr Paul Fleming (British Generic Manufacturers Association)\nMs Jacqueline Mulryne (Arnold & Porter)\nProf. Sir Munir Pirmohamed (NHS Chair of Pharmacogenetics & University of Liverpool)\n\nThe CeBIL Symposium will coincide with the EPIP Annual Conference in Cambridge (14-16 September 2022).
URL:https://remedi4all.org/event/cebil-annual-symposium-2022-intellectual-property-and-drug-repurposing-new-frontiers/
LOCATION:Newnham College\, University of Cambridge\, Sidgwick Avenue\, Cambridge\, CB3 9DF\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://remedi4all.org/wp-content/uploads/2022/08/https-cdn.evbuc_.com-images-286046919-82449972845-1-original.20220517-090934.jpeg
ORGANIZER;CN="Centre for Law%2C Medicine and Life Sciences%2C University of Cambridge":MAILTO:lml@law.cam.ac.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20220902T080000
DTEND;TZID=Europe/Amsterdam:20220903T170000
DTSTAMP:20260423T003205
CREATED:20220818T141600Z
LAST-MODIFIED:20220818T141600Z
UID:224-1662105600-1662224400@remedi4all.org
SUMMARY:REXPO22 – 1st international conference on drug repurposing
DESCRIPTION:The REPO4EU Horizon Europe project to build a European/Global Platform for Drug Repurposing will kick off with the 1st International Conference on Drug Repurposing. \nRExPO22 is the first instalment in the RExPO annual conference series and will take place in Maastricht\, the Netherlands. \nREPO4EU and RExPO22 have partnered with professional societies\, companies\, patent attorneys\, legal and ethics experts\, clinical research organisations\, regulators\, payers\, patient representatives and many more! We have multiple collaborations around the world that pool together their knowledge and know-how to deliver the best possible outcome in the single major opportunity in drug development\, i.e drug repurposing. \nThe speakers include Anton Ussi\, EATRIS Operations and Finance Director\, who will also co-chair the conference. \nFind out more and see the agenda here. Abstract submission is still open here.
URL:https://remedi4all.org/event/rexpo22-1st-international-conference-on-drug-repurposing/
LOCATION:The Function Hall\, Maastricht\, 6229 EP\, Netherlands
ATTACH;FMTTYPE=image/jpeg:https://remedi4all.org/wp-content/uploads/2022/08/https-cdn.evbuc_.com-images-294342909-989138366703-1-original.20220531-085337.jpeg
ORGANIZER;CN="RePo4EU":MAILTO:rexpo@repo4.eu
END:VEVENT
END:VCALENDAR